CYTOMED THERAPEUTICS LTD (GDTC) Stock Analyst Earnings Estimates
NASDAQ:GDTC - Nasdaq - SGXZ17669631 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -8.93% | ||||||
| EBITDA YoY % growth | -640K | -1.56M -143.75% | -1.39M 10.90% | -2.56M -84.17% | -3.56M -39.08% | N/A | N/A | |
| EBIT YoY % growth | -820K | -1.85M -125.61% | -1.72M 7.03% | -2.95M -71.51% | -3.942M -33.61% | N/A 58.96% | N/A -16.39% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 42.31% | N/A -13.33% |
All data in SGD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 20.00% | -0.04 20.00% | -0.04 -33.33% | -0.04 -33.33% | -0.04 | -0.04 |
| Revenue Q2Q % growth | 132.6K | 132.6K | 132.6K -16.67% | 132.6K | 132.6K | 132.6K |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -471.24K | -471.24K 75.88% | -471.24K -39.58% | -471.24K 71.37% | -471.24K | -471.24K |
All data in SGD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |